TrialPloS one2015

Efficacy and Safety of Antiretroviral Therapy Initiated One Week after Tuberculosis Therapy in Patients with CD4 Counts < 200 Cells/μL: TB-HAART Study, a Randomized Clinical Trial.

Wondwossen Amogne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.